Dexcom (DXCM)

Nasdaq Health Care Health Care Equipment S&P 500Nasdaq-100

$79.41

-5.05 (-5.98%)

Close of Nov 06, 2026 · end-of-day data

Source: Dexcom's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$573.30M	$718.50M	$1.03B	$1.48B	$1.93B	$2.45B	$2.91B	$3.62B	$4.03B	$4.66B
Cost of revenue	$194.90M	$226.40M	$367.70M	$544.50M	$646.60M	$768.00M	$1.03B	$1.33B	$1.59B	$1.86B
Gross profit	$378.40M	$492.10M	$663.90M	$931.50M	$1.28B	$1.68B	$1.88B	$2.29B	$2.44B	$2.80B
Research & development	$156.10M	$185.40M	$199.70M	$273.50M	$359.90M	$517.10M	$484.20M	$505.80M	$552.40M	$599.10M
Selling, general & admin	$286.20M	$349.20M	$432.80M	$515.70M	$618.20M	$810.50M	$1.01B	$1.19B	$1.29B	$1.29B
Operating income	-$63.90M	-$42.50M	-$186.30M	$142.30M	$299.50M	$265.80M	$391.20M	$597.70M	$600.00M	$911.80M
Interest expense	$700.00K	$12.80M	$22.70M	$60.30M	$17.70M	$18.80M	$18.60M	$20.30M	$19.00M	$18.30M
Pre-tax income	-$64.90M	-$48.60M	-$126.50M	$104.20M	$297.90M	$256.80M	$390.80M	$710.40M	$709.00M	$1.09B
Income tax	$700.00K	$1.60M	$600.00K	$3.10M	-$251.80M	$39.90M	$49.60M	$168.90M	$132.80M	$252.10M
Net income	-$65.60M	-$50.20M	-$127.10M	$101.10M	$549.70M	$216.90M	$341.20M	$541.50M	$576.20M	$836.30M
EBITDA	-$48.90M	-$26.40M	-$157.20M	$191.00M	$366.60M	$367.80M	$547.10M	$783.70M	$817.70M	$1.16B
EPS (basic)	$-0.78	$-0.58	$-1.44	$1.11	$1.46	$0.56	$0.88	$1.40	$1.46	$2.14
EPS (diluted)	$-0.78	$-0.58	$-1.44	$1.10	$1.33	$0.53	$0.82	$1.30	$1.42	$2.09
Diluted shares	83.60M	86.30M	88.20M	92.30M	420.40M	428.80M	427.50M	425.50M	412.70M	405.50M
Gross margin	66.0%	68.5%	64.4%	63.1%	66.4%	68.6%	64.7%	63.2%	60.5%	60.1%
Operating margin	-11.1%	-5.9%	-18.1%	9.6%	15.5%	10.9%	13.4%	16.5%	14.9%	19.6%
Net margin	-11.4%	-7.0%	-12.3%	6.8%	28.5%	8.9%	11.7%	14.9%	14.3%	17.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$94.50M	$441.50M	$1.14B	$446.20M	$817.60M	$1.05B	$642.30M	$566.30M	$606.10M	$917.70M
Short-term investments	$29.20M	$107.10M	$92.70M	—	—	$1.36B	$1.81B	$2.16B	$1.73B	—
Receivables	$101.70M	$134.30M	$226.70M	$286.30M	$428.50M	$514.30M	$713.30M	$973.90M	$1.01B	$1.22B
Inventory	$45.40M	$45.20M	$70.70M	$119.80M	$234.70M	$357.30M	$306.70M	$559.60M	$542.60M	$629.10M
Total current assets	$280.00M	$744.70M	$1.70B	$1.97B	$3.42B	$3.68B	$3.67B	$4.43B	$4.30B	$4.03B
Goodwill	$11.30M	$12.10M	$18.70M	$18.60M	$19.30M	$26.50M	$25.70M	$25.20M	$22.80M	$24.20M
Total assets	$402.80M	$904.10M	$1.92B	$2.40B	$4.29B	$4.93B	$5.39B	$6.26B	$6.48B	$6.34B
Total current liabilities	$102.40M	$138.90M	$222.40M	$360.20M	$614.10M	$720.80M	$1.84B	$1.56B	$2.93B	$2.14B
Total liabilities	$119.00M	$484.70M	$1.25B	$1.51B	$2.46B	$2.89B	$3.26B	$4.20B	$4.38B	$3.59B
Shareholders' equity	$283.80M	$419.40M	$663.30M	$882.60M	$1.55B	$2.04B	$2.13B	$2.07B	$2.10B	$2.75B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$56.20M	$92.00M	$123.20M	$314.50M	$475.60M	$442.50M	$669.50M	$748.50M	$989.50M	$1.44B
Capital expenditures	$55.70M	$66.00M	$67.10M	$180.00M	$199.00M	$389.20M	$364.80M	$236.60M	$358.80M	$363.50M
Free cash flow	$500.00K	$26.00M	$56.10M	$134.50M	$276.60M	$53.30M	$304.70M	$511.90M	$630.70M	$1.08B
Investing cash flow	-$55.90M	-$144.40M	-$139.80M	-$1.02B	-$1.02B	-$216.10M	-$521.50M	-$507.20M	-$207.50M	$536.00M
Financing cash flow	$8.10M	$399.10M	$710.40M	$10.70M	$912.10M	$10.40M	-$552.50M	-$318.60M	-$734.80M	-$1.69B
Share buybacks	$0	$0	$100.00M	$0	$0	$0	$557.70M	$688.70M	$750.00M	$500.00M
Stock-based compensation	$110.80M	$106.20M	$101.90M	$102.70M	$119.40M	$113.40M	$126.50M	$150.80M	$170.40M	$159.60M
Depreciation & amortization	$15.00M	$16.10M	$29.10M	$48.70M	$67.10M	$102.00M	$155.90M	$186.00M	$217.70M	$251.80M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$1.03B	$921.00M	$1.00B	$994.20M	$1.11B	$1.04B	$1.16B	$1.21B	$1.26B	$1.19B	$1.31B	$1.34B
Cost of revenue	$377.90M	$359.10M	$377.60M	$400.40M	$457.70M	$447.00M	$468.30M	$477.90M	$466.90M	$441.60M	$478.40M	$480.10M
Gross profit	$656.60M	$561.90M	$626.70M	$593.80M	$655.80M	$589.00M	$688.80M	$731.40M	$792.70M	$750.30M	$830.00M	$864.40M
Research & development	$136.10M	$141.50M	$136.00M	$135.40M	$139.50M	$145.20M	$148.20M	$157.50M	$148.20M	$145.30M	$153.00M	$161.60M
Selling, general & admin	$303.60M	$319.30M	$332.70M	$306.40M	$327.40M	$310.10M	$328.00M	$331.40M	$321.50M	$349.70M	$358.70M	$375.60M
Operating income	$216.90M	$101.10M	$158.00M	$152.00M	$188.90M	$133.70M	$212.60M	$242.50M	$323.00M	$255.30M	$318.30M	$327.20M
Interest expense	$4.90M	$4.60M	$4.80M	$4.70M	$4.90M	$4.70M	$4.70M	$4.70M	$4.20M	$3.10M	$3.00M	$3.10M
Pre-tax income	$246.20M	$132.50M	$187.80M	$177.40M	$211.30M	$154.30M	$241.10M	$352.30M	$340.70M	$269.50M	$317.50M	$334.70M
Income tax	-$10.10M	-$13.90M	$44.30M	$42.80M	$59.60M	$48.90M	$61.30M	$68.50M	$73.40M	$70.00M	$68.40M	$59.60M
Net income	$256.30M	$146.40M	$143.50M	$134.60M	$151.70M	$105.40M	$179.80M	$283.80M	$267.30M	$199.50M	$249.10M	$275.10M
EBITDA	$269.40M	$153.60M	$210.10M	$207.30M	$246.70M	$193.70M	$275.60M	$306.10M	$388.20M	$322.40M	$386.50M	$401.70M
EPS (basic)	$0.66	$0.38	$0.36	$0.34	$0.38	$0.27	$0.46	$0.73	$0.69	$0.52	$0.65	$0.73
EPS (diluted)	$0.61	$0.36	$0.35	$0.34	$0.38	$0.27	$0.45	$0.70	$0.67	$0.51	$0.64	$0.72
Diluted shares	-2.80M	416.70M	416.80M	410.20M	-2.00M	407.50M	408.20M	407.40M	-2.20M	393.60M	390.10M	383.50M
Gross margin	63.5%	61.0%	62.4%	59.7%	58.9%	56.9%	59.5%	60.5%	62.9%	62.9%	63.4%	64.3%
Operating margin	21.0%	11.0%	15.7%	15.3%	17.0%	12.9%	18.4%	20.1%	25.6%	21.4%	24.3%	24.3%
Net margin	24.8%	15.9%	14.3%	13.5%	13.6%	10.2%	15.5%	23.5%	21.2%	16.7%	19.0%	20.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$566.30M	$851.20M	$939.20M	$621.20M	$606.10M	$904.90M	$1.16B	$1.84B	$917.70M	$1.12B	$1.10B	$961.40M
Short-term investments	$2.16B	$1.77B	$2.03B	$1.65B	$1.73B	$1.56B	—	—	—	—	—	—
Receivables	$973.90M	$978.60M	$945.20M	$1.00B	$1.01B	$1.16B	$1.35B	$1.11B	$1.22B	$1.09B	$1.26B	$1.19B
Inventory	$559.60M	$589.10M	$570.30M	$586.30M	$542.60M	$538.20M	$570.70M	$604.10M	$629.10M	$693.60M	$726.40M	$770.70M
Total current assets	$4.43B	$4.62B	$4.85B	$4.26B	$4.30B	$4.55B	$5.03B	$5.22B	$4.03B	$4.33B	$4.09B	$3.92B
Goodwill	$25.20M	$23.20M	$23.30M	$23.80M	$22.80M	$23.10M	$24.10M	$24.10M	$24.20M	$24.20M	$24.10M	$24.00M
Total assets	$6.26B	$6.48B	$6.80B	$6.35B	$6.48B	$6.75B	$7.33B	$7.50B	$6.34B	$6.63B	$6.46B	$6.24B
Total current liabilities	$1.56B	$1.59B	$1.72B	$1.73B	$2.93B	$3.04B	$3.31B	$3.34B	$2.14B	$2.22B	$2.36B	$2.25B
Total liabilities	$4.20B	$4.24B	$4.36B	$4.37B	$4.38B	$4.49B	$4.75B	$4.77B	$3.59B	$3.68B	$3.83B	$3.70B
Shareholders' equity	$2.07B	$2.25B	$2.43B	$1.98B	$2.10B	$2.27B	$2.57B	$2.73B	$2.75B	$2.96B	$2.62B	$2.54B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$133.60M	$209.20M	$279.40M	$199.50M	$301.40M	$183.80M	$303.00M	$659.90M	$294.00M	$525.60M	$269.20M	$325.60M
Capital expenditures	$52.50M	$56.90M	$66.10M	$111.20M	$124.60M	$87.00M	$94.10M	$80.50M	$101.90M	$76.60M	$84.70M	$52.90M
Free cash flow	$81.10M	$152.30M	$213.30M	$88.30M	$176.80M	$96.80M	$208.90M	$579.40M	$192.10M	$449.00M	$184.50M	$272.70M
Investing cash flow	$414.90M	$74.80M	-$188.90M	$210.30M	-$303.70M	$100.20M	-$63.60M	$192.80M	$306.60M	-$298.50M	$329.80M	-$76.70M
Financing cash flow	-$631.90M	$4.70M	-$1.40M	-$736.50M	-$1.60M	$12.50M	-$1.70M	-$175.00M	-$1.52B	-$25.00M	-$607.30M	-$391.50M
Share buybacks	$500.00M	—	—	$750.00M	$0	—	—	$187.20M	$312.80M	—	—	$400.00M
Stock-based compensation	$36.90M	$39.00M	$44.70M	$43.40M	$43.30M	$34.20M	$45.30M	$45.10M	$35.00M	$43.30M	$39.00M	$36.80M
Depreciation & amortization	$52.50M	$52.50M	$52.10M	$55.30M	$57.80M	$60.00M	$63.00M	$63.60M	$65.20M	$67.10M	$68.20M	$74.50M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.